HIGHLIGHTS
- who: Tin Man Mandy Lau from the Centre for Trials Research, Cardiff University, Cardiff, UK have published the research work: AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes, in the Journal: (JOURNAL) of 31/07/2018
- what: The aim for the AZTEC trial is to determine the effectiveness of azithromycin in increasing survival without physiologically defined CLD (moderate/ severe) when compared to placebo. The AZTEC trial focuses on IMP ‘initiation' and ‘implementation' as the two adherence elements of interest. The following reasons for withdrawal are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.